Subgrouping of gliomas on the basis of genetic profiles

Yuichi Hirose, Hikaru Sasaki, Masato Abe, Natsuki Hattori, Kazuhide Adachi, Yuya Nishiyama, Shinya Nagahisa, Takuro Hayashi, Mitsuhiro Hasegawa, Kazunari Yoshida

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Management of gliomas depends on histological diagnosis; there are, however, limitations to the systems presently used. Tumors in the same entity can have different clinical courses, especially when they are diagnosed as WHO grade II-III. Previous studies revealed that genetic subgrouping of gliomas provides useful information that could help establishment of treatment procedures on the basis of the genetic background of the tumors. Recently, the authors analyzed the chromosomal copy number aberrations (CNAs) of adult supratentorial gliomas by comparative genomic hybridization using microdissected tissue sections. The tumors were classified into subgroups according to chromosomal CNAs. WHO grade II-III gliomas contained a variety of genetic subgroups that correlated well with the clinical course. Of these, long progression-free survival was observed for tumors with +7q and those with -1p/19q, low-grade tumors of 2 major lineages, and, in our preliminary data, both were closely correlated with mutation of IDH1. Furthermore, in contrast with +7q tumors, the great majority of +7 or +7/-10q groups had wildtype IDH1. Genetic studies suggest that cytogenetic characterization may provide an additional classification system for gliomas, and new criteria could help to establish rational and objective means for analysis of treatment procedures.

Original languageEnglish
Pages (from-to)203-208
Number of pages6
JournalBrain Tumor Pathology
Volume30
Issue number4
DOIs
Publication statusPublished - 2013 Oct

Fingerprint

Glioma
Neoplasms
Comparative Genomic Hybridization
Cytogenetics
Disease-Free Survival
Mutation

Keywords

  • DNA copy number aberrations
  • Genetic subgroup
  • Glioma
  • IDH1

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Clinical Neurology

Cite this

Subgrouping of gliomas on the basis of genetic profiles. / Hirose, Yuichi; Sasaki, Hikaru; Abe, Masato; Hattori, Natsuki; Adachi, Kazuhide; Nishiyama, Yuya; Nagahisa, Shinya; Hayashi, Takuro; Hasegawa, Mitsuhiro; Yoshida, Kazunari.

In: Brain Tumor Pathology, Vol. 30, No. 4, 10.2013, p. 203-208.

Research output: Contribution to journalArticle

Hirose, Y, Sasaki, H, Abe, M, Hattori, N, Adachi, K, Nishiyama, Y, Nagahisa, S, Hayashi, T, Hasegawa, M & Yoshida, K 2013, 'Subgrouping of gliomas on the basis of genetic profiles', Brain Tumor Pathology, vol. 30, no. 4, pp. 203-208. https://doi.org/10.1007/s10014-013-0148-y
Hirose Y, Sasaki H, Abe M, Hattori N, Adachi K, Nishiyama Y et al. Subgrouping of gliomas on the basis of genetic profiles. Brain Tumor Pathology. 2013 Oct;30(4):203-208. https://doi.org/10.1007/s10014-013-0148-y
Hirose, Yuichi ; Sasaki, Hikaru ; Abe, Masato ; Hattori, Natsuki ; Adachi, Kazuhide ; Nishiyama, Yuya ; Nagahisa, Shinya ; Hayashi, Takuro ; Hasegawa, Mitsuhiro ; Yoshida, Kazunari. / Subgrouping of gliomas on the basis of genetic profiles. In: Brain Tumor Pathology. 2013 ; Vol. 30, No. 4. pp. 203-208.
@article{2bb336779d3e470082fd4c7105ea5bda,
title = "Subgrouping of gliomas on the basis of genetic profiles",
abstract = "Management of gliomas depends on histological diagnosis; there are, however, limitations to the systems presently used. Tumors in the same entity can have different clinical courses, especially when they are diagnosed as WHO grade II-III. Previous studies revealed that genetic subgrouping of gliomas provides useful information that could help establishment of treatment procedures on the basis of the genetic background of the tumors. Recently, the authors analyzed the chromosomal copy number aberrations (CNAs) of adult supratentorial gliomas by comparative genomic hybridization using microdissected tissue sections. The tumors were classified into subgroups according to chromosomal CNAs. WHO grade II-III gliomas contained a variety of genetic subgroups that correlated well with the clinical course. Of these, long progression-free survival was observed for tumors with +7q and those with -1p/19q, low-grade tumors of 2 major lineages, and, in our preliminary data, both were closely correlated with mutation of IDH1. Furthermore, in contrast with +7q tumors, the great majority of +7 or +7/-10q groups had wildtype IDH1. Genetic studies suggest that cytogenetic characterization may provide an additional classification system for gliomas, and new criteria could help to establish rational and objective means for analysis of treatment procedures.",
keywords = "DNA copy number aberrations, Genetic subgroup, Glioma, IDH1",
author = "Yuichi Hirose and Hikaru Sasaki and Masato Abe and Natsuki Hattori and Kazuhide Adachi and Yuya Nishiyama and Shinya Nagahisa and Takuro Hayashi and Mitsuhiro Hasegawa and Kazunari Yoshida",
year = "2013",
month = "10",
doi = "10.1007/s10014-013-0148-y",
language = "English",
volume = "30",
pages = "203--208",
journal = "Brain Tumor Pathology",
issn = "1433-7398",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Subgrouping of gliomas on the basis of genetic profiles

AU - Hirose, Yuichi

AU - Sasaki, Hikaru

AU - Abe, Masato

AU - Hattori, Natsuki

AU - Adachi, Kazuhide

AU - Nishiyama, Yuya

AU - Nagahisa, Shinya

AU - Hayashi, Takuro

AU - Hasegawa, Mitsuhiro

AU - Yoshida, Kazunari

PY - 2013/10

Y1 - 2013/10

N2 - Management of gliomas depends on histological diagnosis; there are, however, limitations to the systems presently used. Tumors in the same entity can have different clinical courses, especially when they are diagnosed as WHO grade II-III. Previous studies revealed that genetic subgrouping of gliomas provides useful information that could help establishment of treatment procedures on the basis of the genetic background of the tumors. Recently, the authors analyzed the chromosomal copy number aberrations (CNAs) of adult supratentorial gliomas by comparative genomic hybridization using microdissected tissue sections. The tumors were classified into subgroups according to chromosomal CNAs. WHO grade II-III gliomas contained a variety of genetic subgroups that correlated well with the clinical course. Of these, long progression-free survival was observed for tumors with +7q and those with -1p/19q, low-grade tumors of 2 major lineages, and, in our preliminary data, both were closely correlated with mutation of IDH1. Furthermore, in contrast with +7q tumors, the great majority of +7 or +7/-10q groups had wildtype IDH1. Genetic studies suggest that cytogenetic characterization may provide an additional classification system for gliomas, and new criteria could help to establish rational and objective means for analysis of treatment procedures.

AB - Management of gliomas depends on histological diagnosis; there are, however, limitations to the systems presently used. Tumors in the same entity can have different clinical courses, especially when they are diagnosed as WHO grade II-III. Previous studies revealed that genetic subgrouping of gliomas provides useful information that could help establishment of treatment procedures on the basis of the genetic background of the tumors. Recently, the authors analyzed the chromosomal copy number aberrations (CNAs) of adult supratentorial gliomas by comparative genomic hybridization using microdissected tissue sections. The tumors were classified into subgroups according to chromosomal CNAs. WHO grade II-III gliomas contained a variety of genetic subgroups that correlated well with the clinical course. Of these, long progression-free survival was observed for tumors with +7q and those with -1p/19q, low-grade tumors of 2 major lineages, and, in our preliminary data, both were closely correlated with mutation of IDH1. Furthermore, in contrast with +7q tumors, the great majority of +7 or +7/-10q groups had wildtype IDH1. Genetic studies suggest that cytogenetic characterization may provide an additional classification system for gliomas, and new criteria could help to establish rational and objective means for analysis of treatment procedures.

KW - DNA copy number aberrations

KW - Genetic subgroup

KW - Glioma

KW - IDH1

UR - http://www.scopus.com/inward/record.url?scp=84887252531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887252531&partnerID=8YFLogxK

U2 - 10.1007/s10014-013-0148-y

DO - 10.1007/s10014-013-0148-y

M3 - Article

VL - 30

SP - 203

EP - 208

JO - Brain Tumor Pathology

JF - Brain Tumor Pathology

SN - 1433-7398

IS - 4

ER -